Weber JS - Search Results

1

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition.

Carvajal RD, Lawrence DP, Weber JS, Gajewski TF, Gonzalez R, Lutzky J, O'Day SJ, Hamid O, Wolchok JD, Chapman PB, Sullivan RJ, Teitcher JB, Ramaiya N, Giobbie-Hurder A, Antonescu CR, Heinrich MC, Bastian BC, Corless CL, Fletcher JA, Hodi FS. Carvajal RD, et al. Among authors: weber js. Clin Cancer Res. 2015 May 15;21(10):2289-96. doi: 10.1158/1078-0432.CCR-14-1630. Epub 2015 Feb 18. Clin Cancer Res. 2015. PMID: 25695690 Free PMC article. Clinical Trial.

2

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.

Wang F, Bade E, Kuniyoshi C, Spears L, Jeffery G, Marty V, Groshen S, Weber J. Wang F, et al. Clin Cancer Res. 1999 Oct;5(10):2756-65. Clin Cancer Res. 1999. PMID: 10537339 Clinical Trial.

3

A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma.

Atkins MB, Redman B, Mier J, Gollob J, Weber J, Sosman J, MacPherson BL, Plasse T. Atkins MB, et al. Clin Cancer Res. 2001 Mar;7(3):486-92. Clin Cancer Res. 2001. PMID: 11297238 Clinical Trial.

4

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.

Yu C, Chen JC, Apuzzo ML, O'Day S, Giannotta SL, Weber JS, Petrovich Z. Yu C, et al. Among authors: weber js. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1277-87. doi: 10.1016/s0360-3016(01)02772-9. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955740

5

A phase I trial of SD-9427 (progenipoietin) with a multipeptide vaccine for resected metastatic melanoma.

Pullarkat V, Lee PP, Scotland R, Rubio V, Groshen S, Gee C, Lau R, Snively J, Sian S, Woulfe SL, Wolfe RA, Weber JS. Pullarkat V, et al. Among authors: weber js. Clin Cancer Res. 2003 Apr;9(4):1301-12. Clin Cancer Res. 2003. PMID: 12684398 Clinical Trial.

6

Phase I study of intranodal delivery of a plasmid DNA vaccine for patients with Stage IV melanoma.

Tagawa ST, Lee P, Snively J, Boswell W, Ounpraseuth S, Lee S, Hickingbottom B, Smith J, Johnson D, Weber JS. Tagawa ST, et al. Among authors: weber js. Cancer. 2003 Jul 1;98(1):144-54. doi: 10.1002/cncr.11462. Cancer. 2003. PMID: 12833467 Free article. Clinical Trial.

7

Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma.

Wong R, Lau R, Chang J, Kuus-Reichel T, Brichard V, Bruck C, Weber J. Wong R, et al. Clin Cancer Res. 2004 Aug 1;10(15):5004-13. doi: 10.1158/1078-0432.CCR-04-0241. Clin Cancer Res. 2004. PMID: 15297401 Clinical Trial.

8

Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study.

Liu D, O'Day SJ, Yang D, Boasberg P, Milford R, Kristedja T, Groshen S, Weber J. Liu D, et al. Clin Cancer Res. 2005 Feb 1;11(3):1237-46. Clin Cancer Res. 2005. PMID: 15709194

9

CCI-779 in metastatic melanoma: a phase II trial of the California Cancer Consortium.

Margolin K, Longmate J, Baratta T, Synold T, Christensen S, Weber J, Gajewski T, Quirt I, Doroshow JH. Margolin K, et al. Cancer. 2005 Sep 1;104(5):1045-8. doi: 10.1002/cncr.21265. Cancer. 2005. PMID: 16007689 Free article. Clinical Trial.

10

A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.

Lewis KD, Gibbs P, O'Day S, Richards J, Weber J, Anderson C, Zeng C, Baron A, Russ P, Gonzalez R. Lewis KD, et al. Cancer Invest. 2005;23(4):303-8. doi: 10.1081/cnv-58832. Cancer Invest. 2005. PMID: 16100942 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters